Exploiting the brain tumor environment to make better treatments

GABRIELLA BEER | July 12, 2018

article image
Scientists are used to exploring unfamiliar territories. It’s thanks to centuries of these investigations that we understand most of the human body enough to fix things when they go wrong. Unfortunately, some parts of the body remain somewhat of a mystery. And the brain is perhaps one of the greatest of these unexplored regions. This is one of the reasons why brain tumors are so difficult to treat.

Spotlight

Frontier Behavioral Health

Frontier Behavioral Health was formed in 2011 with the merger of two long-standing organizations: Spokane Mental Health (since 1970) and Family Service Spokane (since 1905). Combined, FBH has more than 100 years of experience providing behavioral healthcare services in Spokane County. FBH is the lead service provider of Crisis Response Services in the region and provides 14-hour crisis intervention services and Involuntary Treatment Act evaluations. FBH serves more than 16,000 clients a year with a staff of more than 700 and provides a full range of services to people of all ages including Children and Youth, Adults and Elders. While the majority of services are provided in an outpatient setting, FBH also operates 48 inpatient beds where Evaluation & Treatment and Stabilization services are provided. Other services provided by FBH include Peer Support, Crisis Services, services in Nursing Homes, Schools, and for the Homeless. FBH also operates a Clubhouse and Vocational Rehab/Emplo

OTHER ARTICLES

Decentralized Clinical Trials: Imperative for Pharma Sector to fight COVID19

Article | April 3, 2020

These are unprecedented times. The world is mobbed by a contagion virus, putting people’s health at risk, threatening to destabilize economies. It has already put global healthcare systems under tremendous pressures, and managed to resist efforts to contain it. Even though coronaviruses are not new, this COVID-19 strain has created panic and forced us to be locked down in our homes sans any movement for weeks, if not months. Organizations are fighting an intense battle to keep their workforce safe, minimize risk, and ensure business continuity. For the Life Sciences industry, however, the challenge is even more significant. The whole world is looking at them to come up with a vaccine and a cure. But that is easier said than done. Bringing a new drug to market is an uphill battle and requires rigorous clinical trials. This process already has regulatory challenges. With the current lockdown situation, the Pharma community is grappled with the challenge of continuing some of the critical and time-sensitive in-flight trials so that their regulatory submission, registration, and market entry are not impacted. But all may not be lost. With the right technology solution, it is possible to turn the situation around rapidly.

Read More

WALGREEN’S IN HOT WATER OVER PHONY PHARMACIST

Article | February 11, 2020

The drugstore chain agreed to pay $7.5 million in fines after an unlicensed pharmacist at several San Francisco Bay locations illegally filled more than 700,000 prescriptions over a ten-year period. According to California prosecutors, Kim Thien Le stole license numbers from other pharmacists to fill prescriptions for Fentanyl, morphine, and other painkillers. Le pleaded guilty to multiple felony impersonation counts. Walgreen’s agreed to the settlement to avoid being charged with consumer fraud in Alameda and Santa Anna Counties. Prosecutors alleged that Walgreen’s failed to verify Le’s license and did not conduct a thorough background check. The company insisted it has taken remedial measures.

Read More

Clinical Development Risks and Issues in a COVID-19 World

Article | March 20, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

Pricing of drugs – at what cost?

Article | February 27, 2020

We go into a doctor’s office and leave with a diagnosis and a prescription. Next we stop by the pharmacy. In Germany, if your insurance is not private, you mostly don’t even know the price of your drug because it’s paid for directly by your insurance. You only notice the 5-10 Euros copay. But how is a drug priced in Germany? And (how) does data play a role in helping pharma secure an attractive price point? Let’s fast forward directly to the launch of a new drug. At the time of launch, the pharmaceutical company has to present patient level evidence of the drug’s added value compared to existing comparative therapies. In the first year, however, the drug’s price can be defined freely by the company.

Read More

Spotlight

Frontier Behavioral Health

Frontier Behavioral Health was formed in 2011 with the merger of two long-standing organizations: Spokane Mental Health (since 1970) and Family Service Spokane (since 1905). Combined, FBH has more than 100 years of experience providing behavioral healthcare services in Spokane County. FBH is the lead service provider of Crisis Response Services in the region and provides 14-hour crisis intervention services and Involuntary Treatment Act evaluations. FBH serves more than 16,000 clients a year with a staff of more than 700 and provides a full range of services to people of all ages including Children and Youth, Adults and Elders. While the majority of services are provided in an outpatient setting, FBH also operates 48 inpatient beds where Evaluation & Treatment and Stabilization services are provided. Other services provided by FBH include Peer Support, Crisis Services, services in Nursing Homes, Schools, and for the Homeless. FBH also operates a Clubhouse and Vocational Rehab/Emplo

Events